Skip to main content
. 2023 May 26;14:1189647. doi: 10.3389/fimmu.2023.1189647

Table 1.

Demographic and clinical characteristics.

Bronchoscopy group (n=41) Non-bronchoscopy group (n=262) P value
Sex Male 25 (61.0%) 143 (54.6%) 0.444
Age 6.96 ± 2.83 4.38 ± 2.80 <0.001
Fever days 7.00 (6.50,10.00) 6.00 (4.00,7.00) <0.001
Hospitalization days 10.00 (8.00,14.00) 8.00 (7.00,9.00) <0.001
WBC (× 109/L) 9.70 ± 4.05 9.12 ± 3.64 0.352
Neutrophils (× 109/L) 6.53 ± 3.16 5.15 ± 3.25 0.012
CRP (mg/L) <8 16 (39.0%) 146 (55.7%) 0.046
>8 17.00 (10.50,35.50) 11.00 (8.00,21.40)
HB (g/L) 125.29 ± 11.22 126.07± 19.57 0.805
PLT (× 109/L) 279.00 (224.00,351.50) 252.00 (200.00,329.00) 0.244
ALT (U/L) 18.00 (12.25,26.00) 13.00 (9.00,16.00) <0.001
AST (U/L) 32.50 (24.50,44.00) 29.00 (23.00,35.00) 0.082
LDH (U/L) 419.00 (301.25,556.75) 323.00 (279.00,393.00) 0.002
CK-MB (U/L) 20.00 (16.25,25.75) 21.00 (18.00,26.75) 0.324
Pleural reaction Yes 5 (12.2%) 10 (3.8%) 0.056
Pleural effusion Yes 13 (31.7%) 11 (4.2%) <0.001
Atelectasis Yes 11 (26.8%) 8 (3.1%) <0.001

Quantitative normal or nearly normal data are expressed as the mean ± standard deviation and analyzed by the t-test. Quantitative skewness data are presented as the median (percentile: P25, P75) and analyzed by the Wilcoxon-Mann-Whitney rank-sum test. Categorical data are expressed as the frequency and analyzed by the chi-square test. WBC, white blood cell; CRP, C-reactive protein; HB, hemoglobin; PLT, platelet; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDH, lactate dehydrogenase; CK-MB, creatine kinase-MB.